Atlas Trials

HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection

Clinical trial NCT02660905 · COMPLETED

Trial details

NCT number
NCT02660905
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Human Immunodeficiency VirusHepatitis C, Chronic
Start date
2016-04-01
Primary completion
2018-01-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.